| UniProt ID | FACE1_HUMAN | |
|---|---|---|
| UniProt AC | O75844 | |
| Protein Name | CAAX prenyl protease 1 homolog | |
| Gene Name | ZMPSTE24 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 475 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Nucleus inner membrane Multi-pass membrane protein . |
|
| Protein Description | Proteolytically removes the C-terminal three residues of farnesylated proteins. Acts on lamin A/C.. | |
| Protein Sequence | MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MGMWASLDALWEM --CCCCCCHHHHHCC | 15.98 | - | |
| 35 | Phosphorylation | WTVYLWETFLAQRQR HHHHHHHHHHHHHHH | 16.62 | - | |
| 45 | Phosphorylation | AQRQRRIYKTTTHVP HHHHHHHHHCCCCCC | 10.64 | - | |
| 46 | Ubiquitination | QRQRRIYKTTTHVPP HHHHHHHHCCCCCCC | 36.70 | 21906983 | |
| 61 | Phosphorylation | ELGQIMDSETFEKSR HHHCCCCCHHHCHHH | 22.58 | - | |
| 66 | Ubiquitination | MDSETFEKSRLYQLD CCCHHHCHHHCEECC | 36.36 | 21906983 | |
| 67 | Phosphorylation | DSETFEKSRLYQLDK CCHHHCHHHCEECCH | 21.96 | - | |
| 233 | Ubiquitination | FTPLPEGKLKEEIEV CCCCCCCCCHHHHHH | 55.51 | 33845483 | |
| 235 | Ubiquitination | PLPEGKLKEEIEVMA CCCCCCCHHHHHHHH | 57.71 | 22817900 | |
| 243 | Ubiquitination | EEIEVMAKSIDFPLT HHHHHHHHHCCCCCC | 29.83 | 21963094 | |
| 244 | Phosphorylation | EIEVMAKSIDFPLTK HHHHHHHHCCCCCCE | 20.18 | 21712546 | |
| 250 | Phosphorylation | KSIDFPLTKVYVVEG HHCCCCCCEEEEEEC | 20.78 | 18452278 | |
| 251 | Ubiquitination | SIDFPLTKVYVVEGS HCCCCCCEEEEEECC | 38.97 | 21906983 | |
| 253 | Phosphorylation | DFPLTKVYVVEGSKR CCCCCEEEEEECCCC | 10.59 | 28152594 | |
| 259 | Ubiquitination | VYVVEGSKRSSHSNA EEEEECCCCCCCCCC | 68.13 | 21906983 | |
| 259 | 2-Hydroxyisobutyrylation | VYVVEGSKRSSHSNA EEEEECCCCCCCCCC | 68.13 | - | |
| 261 | Phosphorylation | VVEGSKRSSHSNAYF EEECCCCCCCCCCEE | 35.82 | 29214152 | |
| 262 | Phosphorylation | VEGSKRSSHSNAYFY EECCCCCCCCCCEEE | 34.66 | 29214152 | |
| 264 | Phosphorylation | GSKRSSHSNAYFYGF CCCCCCCCCCEEEEE | 25.71 | 29214152 | |
| 292 | Ubiquitination | EEYSVLNKDIQEDSG HHHHHHCCHHHCCCC | 52.64 | 29967540 | |
| 298 | Phosphorylation | NKDIQEDSGMEPRNE CCHHHCCCCCCCCCC | 39.01 | 25159151 | |
| 300 | Sulfoxidation | DIQEDSGMEPRNEEE HHHCCCCCCCCCCCC | 8.09 | 21406390 | |
| 310 | Phosphorylation | RNEEEGNSEEIKAKV CCCCCCCHHHHHHHH | 47.68 | 25159151 | |
| 314 | Ubiquitination | EGNSEEIKAKVKNKK CCCHHHHHHHHHCCC | 45.49 | 21906983 | |
| 316 | Ubiquitination | NSEEIKAKVKNKKQG CHHHHHHHHHCCCCC | 49.06 | 22817900 | |
| 318 | Ubiquitination | EEIKAKVKNKKQGCK HHHHHHHHCCCCCCC | 63.44 | 22817900 | |
| 320 | Ubiquitination | IKAKVKNKKQGCKNE HHHHHHCCCCCCCCH | 40.53 | 23503661 | |
| 325 | Ubiquitination | KNKKQGCKNEEVLAV HCCCCCCCCHHHHHH | 74.37 | 29967540 | |
| 325 | Acetylation | KNKKQGCKNEEVLAV HCCCCCCCCHHHHHH | 74.37 | 26051181 | |
| 341 | Ubiquitination | GHELGHWKLGHTVKN CHHHCHHHHCHHHHH | 38.63 | 29967540 | |
| 423 | 2-Hydroxyisobutyrylation | FQADAFAKKLGKAKD HCHHHHHHHHCCHHH | 41.92 | - | |
| 427 | Acetylation | AFAKKLGKAKDLYSA HHHHHHCCHHHHHHH | 63.80 | 12435105 | |
| 429 | Malonylation | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 26320211 | |
| 429 | Ubiquitination | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 33845483 | |
| 429 | Acetylation | AKKLGKAKDLYSALI HHHHCCHHHHHHHHH | 52.32 | 12435115 | |
| 432 | Phosphorylation | LGKAKDLYSALIKLN HCCHHHHHHHHHHHC | 11.30 | 21406692 | |
| 433 | Phosphorylation | GKAKDLYSALIKLNK CCHHHHHHHHHHHCC | 24.72 | 21406692 | |
| 437 | Ubiquitination | DLYSALIKLNKDNLG HHHHHHHHHCCCCCC | 47.02 | 23000965 | |
| 440 | Ubiquitination | SALIKLNKDNLGFPV HHHHHHCCCCCCCCH | 59.43 | 23000965 | |
| 470 | Malonylation | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | 26320211 | |
| 470 | Acetylation | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | 25953088 | |
| 470 | Ubiquitination | LERLQALKTMKQH-- HHHHHHHHHHHCC-- | 49.98 | - | |
| 473 | Ubiquitination | LQALKTMKQH----- HHHHHHHHCC----- | 50.91 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FACE1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FACE1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FACE1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| OST48_HUMAN | DDOST | physical | 22939629 | |
| S10AA_HUMAN | S100A10 | physical | 22939629 | |
| MGST3_HUMAN | MGST3 | physical | 22939629 | |
| VATH_HUMAN | ATP6V1H | physical | 22939629 | |
| NDUB7_HUMAN | NDUFB7 | physical | 22939629 | |
| TMM43_HUMAN | TMEM43 | physical | 22939629 | |
| SYJ2B_HUMAN | SYNJ2BP | physical | 22939629 | |
| RAB5C_HUMAN | RAB5C | physical | 22939629 | |
| GALT2_HUMAN | GALNT2 | physical | 22939629 | |
| HNRPF_HUMAN | HNRNPF | physical | 22939629 | |
| RT05_HUMAN | MRPS5 | physical | 22939629 | |
| VDAC1_HUMAN | VDAC1 | physical | 22939629 | |
| HNRL1_HUMAN | HNRNPUL1 | physical | 22939629 | |
| K2013_HUMAN | KIAA2013 | physical | 22939629 | |
| PTN1_HUMAN | PTPN1 | physical | 22939629 | |
| RM40_HUMAN | MRPL40 | physical | 22939629 | |
| RAB10_HUMAN | RAB10 | physical | 22939629 | |
| CLH1_HUMAN | CLTC | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00663 | Restrictive dermopathy | |||||
| H00665 | Mandibuloacral dysplasia | |||||
| OMIM Disease | ||||||
| 608612 | Mandibuloacral dysplasia with type B lipodystrophy (MADB) | |||||
| 275210 | Lethal tight skin contracture syndrome (LTSCS) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY. | |